Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fovea Pharmaceuticals SA

Division of Sanofi
www.fovea-pharma.com

Latest From Fovea Pharmaceuticals SA

Finance Watch: Two More US Biopharma IPOs And Two New European VC Funds

Two biopharma IPOs in the US continue streak of (mostly) positive returns; two new European VC funds launch as Irish antibiotic developer raises $65m; and Halozyme, Ziopharm price offerings.

Business Strategies Commercial

With Precedents In Place, GenSight Eyes Gene Therapies For Orphan Disorders

The Paris-based start-up has raised €32 million from venture investors to address two orphan eye disorders, taking advantage of new research and manufacturing techniques in gene therapy.

BioPharmaceutical France

Financings of the Fortnight Comes Bearing Gifts

Plus recent news on Amarin, Moderna Therapeutics, ArmaGen and Flexion

BioPharmaceutical Deals

British Biotechs Urge U.K. Government To Import French Private Investment Vehicle

British biotech companies want the U.K. government to adopt a French method of funneling funds into the cash-strapped sector from private individuals in return for favorable rates of investment tax, on grounds that a version of France’s long-running Fonds Commun de Placement dans l'Innovation is needed for small-to-medium-sized biopharma companies in Britain to tap successfully into long-term seed capital.

BioPharmaceutical United Kingdom
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Bernard Gilly, PhD, Chmn. & CEO
    Ulrich Adom, CFO
    Soraya Bekkali, MD, CMO
  • Contact Info
  • Fovea Pharmaceuticals SA
    Phone: (33) 44 16 42 42
    Institut de la Vision
    17 rue Moreau
    Paris, 75012
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register